BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15389640)

  • 1. Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
    Fuchs M; Hermannstädter C; Specht K; Knyazev P; Ullrich A; Rosivatz E; Busch R; Hutzler P; Höfler H; Luber B
    J Cell Physiol; 2005 Mar; 202(3):805-13. PubMed ID: 15389640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis.
    Kremer M; Quintanilla-Martinez L; Fuchs M; Gamboa-Dominguez A; Haye S; Kalthoff H; Rosivatz E; Hermannstädter C; Busch R; Höfler H; Luber B
    Carcinogenesis; 2003 Dec; 24(12):1879-86. PubMed ID: 12949051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
    Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
    Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
    Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein.
    Fuchs M; Hutzler P; Handschuh G; Hermannstädter C; Brunner I; Höfler H; Luber B
    Cell Motil Cytoskeleton; 2004 Sep; 59(1):50-61. PubMed ID: 15259055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences.
    Handschuh G; Luber B; Hutzler P; Höfler H; Becker KF
    J Mol Biol; 2001 Nov; 314(3):445-54. PubMed ID: 11846558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.
    Llorens A; Rodrigo I; López-Barcons L; Gonzalez-Garrigues M; Lozano E; Vinyals A; Quintanilla M; Cano A; Fabra A
    Lab Invest; 1998 Sep; 78(9):1131-42. PubMed ID: 9759657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
    Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
    Deplazes J; Fuchs M; Rauser S; Genth H; Lengyel E; Busch R; Luber B
    Hum Mol Genet; 2009 Oct; 18(19):3632-44. PubMed ID: 19584084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F; Behrens J
    Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological significance of E-cadherin in an inflammatory breast carcinoma cell line].
    Dong HM; Liu G; Wu J; Lu JS; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):4-7. PubMed ID: 16737610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage.
    Fuchs M; Hermannstädter C; Hutzler P; Häcker G; Haller F; Höfler H; Luber B
    Exp Cell Res; 2008 Jan; 314(1):153-63. PubMed ID: 17959171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
    Karmakar S; Das C
    J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.